Tandlægeselskabet Godt Smil Odense M ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  0.5% 0.5% 0.5% 0.5% 0.5%  
Bankruptcy risk  2.7% 2.1% 1.5% 1.5% 2.5%  
Credit score (0-100)  60 66 76 75 62  
Credit rating  BBB A A A BBB  
Credit limit (kDKK)  0.0 0.4 19.5 22.1 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Gross profit  5,525 9,637 9,667 12,484 13,375  
EBITDA  1,082 2,169 2,003 2,298 1,723  
EBIT  349 1,350 1,171 1,100 400  
Pre-tax profit (PTP)  147.3 1,213.9 1,033.8 805.7 43.3  
Net earnings  113.4 952.7 808.4 640.5 40.0  
Pre-tax profit without non-rec. items  147 1,214 1,034 806 43.3  

 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Tangible assets total  5,635 4,928 4,177 8,245 7,605  
Shareholders equity total  1,177 2,130 1,938 2,579 2,369  
Interest-bearing liabilities  265 3,058 2,779 5,413 4,882  
Balance sheet total (assets)  7,247 7,508 6,268 11,103 10,923  

Net Debt  37.2 2,212 2,608 5,291 4,591  
 
See the entire balance sheet

Volume 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  5,525 9,637 9,667 12,484 13,375  
Gross profit growth  0.0% 74.4% 0.3% 29.1% 7.1%  
Employees  7 11 12 17 19  
Employee growth %  0.0% 57.1% 9.1% 41.7% 11.8%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  7,247 7,508 6,268 11,103 10,923  
Balance sheet change%  0.0% 3.6% -16.5% 77.1% -1.6%  
Added value  1,082.1 2,168.7 2,003.5 1,932.3 1,723.5  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  4,902 -1,527 -1,583 2,870 -1,964  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  1.0 2.0 3.0 4.0 5.0  

Profitability 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  6.3% 14.0% 12.1% 8.8% 3.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  4.9% 18.9% 17.5% 13.6% 4.1%  
ROI %  7.8% 28.3% 24.1% 18.6% 6.0%  
ROE %  9.6% 57.6% 39.7% 28.4% 1.6%  

Solidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Equity ratio %  16.7% 29.4% 31.9% 23.6% 22.1%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  3.4% 102.0% 130.2% 230.3% 266.4%  
Gearing %  22.5% 143.6% 143.4% 209.9% 206.1%  
Net interest  0 0 0 0 0  
Financing costs %  159.1% 11.0% 5.8% 9.1% 8.0%  

Liquidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Quick Ratio  0.3 0.7 0.7 0.3 0.4  
Current Ratio  0.4 0.8 0.8 0.5 0.5  
Cash and cash equivalent  227.5 845.6 171.6 121.7 291.2  

Capital use efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -1,841.7 -488.4 -320.9 -1,870.3 -2,074.8  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales / employee  0 0 0 0 0  
Added value / employee  155 197 167 114 91  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  155 197 167 135 91  
EBIT / employee  50 123 98 65 21  
Net earnings / employee  16 87 67 38 2